Stopping long‐acting beta2‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids

Overview of attention for article published in Cochrane database of systematic reviews, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 1 news outlet
twitter: 18 X users

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 141 Mendeley

Summary News X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 27 X posts from 18 X users, with an upper bound of 170,669 followers.

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. - PubMed - NCBI https://t.co/vssKa46TlO

28 Nov 2018

Reply Repost Favourite

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. - PubMed - NCBI https://t.co/eBJXi1zDLw

15 Aug 2018

Reply Repost Favourite

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled… https://t.co/vXTfQ5Eilt

11 Feb 2016

Reply Repost Favourite

RT @cochranecollab: RT @tlassers Step down & stop? @CochraneAirways review looks at effects of reducing #LABAs in well-controlled #asthma h…

30 Oct 2015

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 23 additional X posts.